EOM Pharmaceuticals Holdings, Inc. (OTCMKTS:IMUC – Get Free Report) was down 5.3% during mid-day trading on Tuesday . The stock traded as low as $0.13 and last traded at $0.16. Approximately 1,662 shares traded hands during mid-day trading, a decline of 64% from the average daily volume of 4,654 shares. The stock had previously closed at $0.17.
EOM Pharmaceuticals Stock Down 5.3 %
The stock has a fifty day moving average of $0.17 and a 200-day moving average of $0.15.
EOM Pharmaceuticals Company Profile
Immunocellular Therapeutics, Ltd., a clinical-stage pharmaceutical company, focuses on the development of therapeutics and delivery technologies for the treatment of inflammatory conditions and ocular diseases. Its lead clinical asset is EOM613 solution, a peptide nucleic-acid solution with anti-inflammatory and pro-inflammatory effects on cytokines and chemokines for the treatment of cancer cachexia and rheumatoid arthritis.
Featured Stories
- Five stocks we like better than EOM Pharmaceuticals
- How to Invest in Blue Chip Stocks
- The Fed Is More Likely to Hike Than Cut Rates in 2025
- Basic Materials Stocks Investing
- Investors Navigate Uncertainty by Seeking Refuge in Gold and Oil
- The Basics of Support and Resistance
- Archer Aviation Shares Slide, Now Bargain Priced for 2025
Receive News & Ratings for EOM Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for EOM Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
